why choose us

First received: September 07, 2023

Clinical Trial: Repurposing Valsartan May Protect Against Pulmonary Hypertension

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Pulmonary Arterial Hypertension

Study Type: INTERVENTIONAL


Official Title: Repurposing Valsartan May Protect Against Pulmonary Hypertension

Brief Summary: This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension.The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.

Read more